Reduction of IFN-I responses by plasmacytoid dendritic cells in a longitudinal trans men cohortBenjamin Grünhagel, Marcus Altfeld, Rebecca-Jo Thiele et al.|iScience|2023Cited by 33
New treatment targets in autoimmune hepatitis: detection using integrative omics and target validation in a proof of concept phase II clinical trialJan Philipp Weltzsch, Ansgar W. Lohse, Yang Xu et al.|Zeitschrift für Gastroenterologie|2025Cited by 0
THU-311-YI Uncovering novel therapeutic targets for autoimmune hepatitis (AIH): detection via omics integration and validation in proof-of- concept clinical trialYang Xu, Ansgar W. Lohse, Jan Philipp Weltzsch et al.|Journal of Hepatology|2025Cited by 0